These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10416863)

  • 1. Measuring the cochlear blood flow and distortion-product otoacoustic emissions during reversible cochlear ischemia: a rabbit model.
    Mom T; Telischi FF; Martin GK; Lonsbury-Martin BL
    Hear Res; 1999 Jul; 133(1-2):40-52. PubMed ID: 10416863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cochlear ischemia: from fundamental data to clinical hope].
    Mom T; Gilain L; Avan P
    Ann Otolaryngol Chir Cervicofac; 2008 Dec; 125(6):301-8. PubMed ID: 18926520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early effects of cerebellopontine angle compression on rabbit distortion-product otoacoustic emissions: a model for monitoring cochlear function during acoustic neuroma surgery.
    Widick MP; Telischi FF; Lonsbury-Martin BL; Stagner BB
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):407-16. PubMed ID: 7936673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of real time monitoring of the cochlear function during an induced local ischemia.
    Morawski K; Telischi FF; Niemczyk K
    Hear Res; 2006 Feb; 212(1-2):117-27. PubMed ID: 16403609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mannitol in reducing postischemic changes in distortion-product otoacoustic emissions (DPOAEs): a rabbit model.
    Morawski K; Telischi FF; Merchant F; Abiy LW; Lisowska G; Namyslowski G
    Laryngoscope; 2003 Sep; 113(9):1615-22. PubMed ID: 12972944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reversible ischemia model in gerbil cochlea.
    Ren T; Brown NJ; Zhang M; Nuttall AL; Miller JM
    Hear Res; 1995 Dec; 92(1-2):30-7. PubMed ID: 8647743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the auditory-evoked brainstem response wave I to distortion-product otoacoustic emissions resulting from changes to inner ear blood flow.
    Telischi FF; Mom T; Agrama M; Stagner BB; Ozdamar O; Bustillo A; Martin GK
    Laryngoscope; 1999 Feb; 109(2 Pt 1):186-91. PubMed ID: 10890763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-Doppler measurements and electrocochleography during ischemia of the guinea pig cochlea: implications for hearing preservation in acoustic neuroma surgery.
    Levine RA; Bu-Saba N; Brown MC
    Ann Otol Rhinol Laryngol; 1993 Feb; 102(2):127-36. PubMed ID: 8427498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative monitoring of cochlear function using distortion product otoacoustic emissions (DPOAEs) in patients with cerebellopontine angle tumors.
    Morawski K; Namyslowski G; Lisowska G; Bazowski P; Kwiek S; Telischi FF
    Otol Neurotol; 2004 Sep; 25(5):818-25. PubMed ID: 15354017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion-product otoacoustic emission monitoring of cochlear blood flow.
    Telischi FF; Stagner B; Widick MP; Balkany TJ; Lonsbury-Martin BL
    Laryngoscope; 1998 Jun; 108(6):837-42. PubMed ID: 9628498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasospasm of the internal auditory artery: significance in cerebellopontine angle surgery.
    Mom T; Telischi FF; Martin GK; Stagner BB; Lonsbury-Martin BL
    Am J Otol; 2000 Sep; 21(5):735-42. PubMed ID: 10993468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear ischemia induced by circulating iron particles under magnetic control: an animal model for sudden hearing loss.
    Schweinfurth JM; Cacace AT
    Am J Otol; 2000 Sep; 21(5):636-40. PubMed ID: 10993450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability of the gerbil cochlea to sound exposure during reversible ischemia.
    Mom T; Bonfils P; Gilain L; Avan P
    Hear Res; 1999 Oct; 136(1-2):65-74. PubMed ID: 10511625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of functional changes after transient ischemia in gerbil cochlea.
    Mom T; Avan P; Romand R; Gilain L
    Brain Res; 1997 Mar; 751(1):20-30. PubMed ID: 9098564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of cochlear hearing status in dogs using evoked otoacoustic emissions.
    Gonçalves R; McBrearty A; Pratola L; Calvo G; Anderson TJ; Penderis J
    J Small Anim Pract; 2012 Jun; 53(6):344-51. PubMed ID: 22647213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
    Avan P; Bonfils P; Gilain L; Mom T
    J Acoust Soc Am; 2003 Jan; 113(1):430-41. PubMed ID: 12558280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing hearing damage using topical dexamethasone during reversible cochlear ischemia: an animal model.
    Morawski K; Telischi FF; Bohorquez J; Niemczyk K
    Otol Neurotol; 2009 Sep; 30(6):851-7. PubMed ID: 19638939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of cochlear function assessment during reversible ischemia in the Mongolian gerbil.
    Mom T; Avan P; Bonfils P; Gilain L
    Brain Res Brain Res Protoc; 1999 Dec; 4(3):249-57. PubMed ID: 10592332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.